Clinical Trial Update: Change the Dose Frequency of Controlled-Release Oxycodone to Refractory Pain [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating a change in dosing frequency for controlled-release oxycodone in refractory cancer pain was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Pain

Drugs mentioned

• Controlled-release oxycodone (oxycodone controlled-release)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Cancer Pains | Phase 4 | Status: WITHDRAWN